Tag: Migraine
Ubrogepant Superior to Placebo for Migraine Pain Relief
More participants reported pain freedom at two hours with 50-mg, 25-mg ubrogepant versus placebo
Migraines Linked to Higher Risk for Dementia, Alzheimer Disease
However, no link seen between migraines and vascular dementia
Facial Involvement in Primary Headaches Occurs Infrequently
Facial pain reported as independent or additional symptom in 291 patients of 2,912 patient data sets
Evidence Supports Meds Used for Pain Relief in Pediatric Migraine
But evidence insufficient to assess impact of many treatments to reduce headache frequency in youth
Excess Caffeine May Be a Trigger for Episodic Migraine Headaches
Three or more servings of caffeinated beverages associated with higher odds for headache that day
Rimegepant Shows Promise for Relief From Migraine Attacks
Increase seen in percentage of patients free from pain, from their most bothersome symptom at two hours
Adverse Outcomes Up for Pregnant Women With Migraine
Increased risk for several neonatal, postnatal outcomes for offspring exposed to maternal migraine
Migraine Prevalence Up for Food-Insecure Young Adults
Odds of migraine higher for food-insecure versus food-secure in unadjusted, adjusted analyses
Progressive Muscle Relaxation App Tied to Fewer Migraines
But patients with depression scores were less likely to use either a headache diary or the app
Migraines in Pregnancy Tied to Worse Outcomes for Mother, Baby
Poor outcomes seen in pregnancy for women and at birth, neonatal, and postnatal periods for infants
